Steve Valiquette
Stock Analyst at Barclays
(1.93)
# 2,916
Out of 4,784 analysts
173
Total ratings
47.37%
Success rate
-3.29%
Average return
Main Sectors:
Stocks Rated by Steve Valiquette
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| TDOC Teladoc Health | Maintains: Overweight | $10 → $12 | $8.09 | +48.33% | 13 | Oct 31, 2024 | |
| WBA Walgreens Boots Alliance | Maintains: Underweight | $7 → $8 | $11.19 | -28.51% | 15 | Oct 16, 2024 | |
| MCK McKesson | Maintains: Overweight | $596 → $616 | $668.06 | -7.79% | 6 | Aug 8, 2024 | |
| GDRX GoodRx Holdings | Maintains: Overweight | $8 → $9 | $4.50 | +100.00% | 7 | Mar 1, 2024 | |
| HOUS Anywhere Real Estate | Maintains: Underweight | $4.5 → $5 | $3.46 | +44.51% | 3 | Feb 20, 2024 | |
| MPW Medical Properties Trust | Maintains: Overweight | $12 → $10 | $6.04 | +65.56% | 5 | Aug 22, 2023 | |
| HR Healthcare Realty Trust | Maintains: Equal-Weight | $25 → $24 | $16.76 | +43.20% | 4 | Aug 11, 2023 | |
| CVS CVS Health | Maintains: Overweight | $89 → $86 | $67.14 | +28.09% | 14 | Aug 3, 2023 | |
| CNC Centene | Maintains: Overweight | $86 → $85 | $60.04 | +41.57% | 6 | Jul 31, 2023 | |
| HCA HCA Healthcare | Maintains: Equal-Weight | $275 → $300 | $342.16 | -12.32% | 4 | Jun 28, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $93 → $88 | $92.70 | -5.07% | 3 | May 5, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Underweight | $35 → $34 | $35.25 | -3.55% | 3 | May 3, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $70 → $105 | $133.14 | -21.14% | 3 | Apr 26, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $57 → $55 | $68.76 | -20.01% | 3 | Apr 25, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $15 → $13 | $17.54 | -25.88% | 11 | Apr 25, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Equal-Weight | $132 → $142 | $186.18 | -23.73% | 2 | Apr 25, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Underweight | $13 → $5 | $22.70 | -77.97% | 4 | Apr 5, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Equal-Weight | $57 | $100.78 | -43.44% | 2 | Mar 14, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $78 → $82 | $153.42 | -46.55% | 5 | Jan 17, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $20 → $18 | $20.19 | -10.85% | 2 | Jan 17, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $33 → $31 | $38.08 | -18.59% | 2 | Jan 17, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $400 → $375 | $322.85 | +16.15% | 3 | Jan 4, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $20 → $19 | $28.96 | -34.39% | 2 | Oct 21, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $8 → $7 | $6.15 | +13.82% | 2 | Oct 21, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $500 → $570 | $264.58 | +115.44% | 4 | Jul 28, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Equal-Weight | $70 → $64 | $136.44 | -53.09% | 4 | May 26, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $275 → $310 | $325.04 | -4.63% | 16 | May 23, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $495 → $565 | $516.04 | +9.49% | 3 | Mar 30, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Equal-Weight | $150 → $75 | $12.38 | +505.82% | 4 | Nov 10, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Overweight | $26 → $19 | $3.00 | +533.33% | 2 | Aug 12, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Underweight | $6 → $10 | $2.70 | +270.37% | 10 | Aug 3, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Underweight | $42 → $34 | $19.14 | +77.64% | 4 | May 28, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $20 | $5.37 | +272.44% | 1 | May 24, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reinstates: Overweight | $260 | $105.28 | +146.96% | 1 | Feb 19, 2021 |
Teladoc Health
Oct 31, 2024
Maintains: Overweight
Price Target: $10 → $12
Current: $8.09
Upside: +48.33%
Walgreens Boots Alliance
Oct 16, 2024
Maintains: Underweight
Price Target: $7 → $8
Current: $11.19
Upside: -28.51%
McKesson
Aug 8, 2024
Maintains: Overweight
Price Target: $596 → $616
Current: $668.06
Upside: -7.79%
GoodRx Holdings
Mar 1, 2024
Maintains: Overweight
Price Target: $8 → $9
Current: $4.50
Upside: +100.00%
Anywhere Real Estate
Feb 20, 2024
Maintains: Underweight
Price Target: $4.5 → $5
Current: $3.46
Upside: +44.51%
Medical Properties Trust
Aug 22, 2023
Maintains: Overweight
Price Target: $12 → $10
Current: $6.04
Upside: +65.56%
Healthcare Realty Trust
Aug 11, 2023
Maintains: Equal-Weight
Price Target: $25 → $24
Current: $16.76
Upside: +43.20%
CVS Health
Aug 3, 2023
Maintains: Overweight
Price Target: $89 → $86
Current: $67.14
Upside: +28.09%
Centene
Jul 31, 2023
Maintains: Overweight
Price Target: $86 → $85
Current: $60.04
Upside: +41.57%
HCA Healthcare
Jun 28, 2023
Maintains: Equal-Weight
Price Target: $275 → $300
Current: $342.16
Upside: -12.32%
May 5, 2023
Maintains: Equal-Weight
Price Target: $93 → $88
Current: $92.70
Upside: -5.07%
May 3, 2023
Maintains: Underweight
Price Target: $35 → $34
Current: $35.25
Upside: -3.55%
Apr 26, 2023
Maintains: Overweight
Price Target: $70 → $105
Current: $133.14
Upside: -21.14%
Apr 25, 2023
Maintains: Overweight
Price Target: $57 → $55
Current: $68.76
Upside: -20.01%
Apr 25, 2023
Maintains: Equal-Weight
Price Target: $15 → $13
Current: $17.54
Upside: -25.88%
Apr 25, 2023
Upgrades: Equal-Weight
Price Target: $132 → $142
Current: $186.18
Upside: -23.73%
Apr 5, 2023
Maintains: Underweight
Price Target: $13 → $5
Current: $22.70
Upside: -77.97%
Mar 14, 2023
Initiates: Equal-Weight
Price Target: $57
Current: $100.78
Upside: -43.44%
Jan 17, 2023
Maintains: Overweight
Price Target: $78 → $82
Current: $153.42
Upside: -46.55%
Jan 17, 2023
Maintains: Overweight
Price Target: $20 → $18
Current: $20.19
Upside: -10.85%
Jan 17, 2023
Maintains: Equal-Weight
Price Target: $33 → $31
Current: $38.08
Upside: -18.59%
Jan 4, 2023
Maintains: Overweight
Price Target: $400 → $375
Current: $322.85
Upside: +16.15%
Oct 21, 2022
Maintains: Equal-Weight
Price Target: $20 → $19
Current: $28.96
Upside: -34.39%
Oct 21, 2022
Maintains: Overweight
Price Target: $8 → $7
Current: $6.15
Upside: +13.82%
Jul 28, 2022
Maintains: Overweight
Price Target: $500 → $570
Current: $264.58
Upside: +115.44%
May 26, 2022
Downgrades: Equal-Weight
Price Target: $70 → $64
Current: $136.44
Upside: -53.09%
May 23, 2022
Maintains: Overweight
Price Target: $275 → $310
Current: $325.04
Upside: -4.63%
Mar 30, 2022
Maintains: Overweight
Price Target: $495 → $565
Current: $516.04
Upside: +9.49%
Nov 10, 2021
Downgrades: Equal-Weight
Price Target: $150 → $75
Current: $12.38
Upside: +505.82%
Aug 12, 2021
Upgrades: Overweight
Price Target: $26 → $19
Current: $3.00
Upside: +533.33%
Aug 3, 2021
Maintains: Underweight
Price Target: $6 → $10
Current: $2.70
Upside: +270.37%
May 28, 2021
Downgrades: Underweight
Price Target: $42 → $34
Current: $19.14
Upside: +77.64%
May 24, 2021
Initiates: Overweight
Price Target: $20
Current: $5.37
Upside: +272.44%
Feb 19, 2021
Reinstates: Overweight
Price Target: $260
Current: $105.28
Upside: +146.96%